anxiety and glp-1 The risk of depression, anxiety, suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy GLP-1 diabetes drugs could stop

June 3, 2026 PDRN for Stretch Marks: What the Clinical Evidence Says and How the Treatment Works Searches for PDRN and stretch marks have grown substantially over the past year, but the first page of results is dominated by topical serums and social media content

Recent News 12 items

Published preclinical studies have examined BPC-157 across gastrointestinal tissue (NSAID-induced injury, alcohol-induced damage, inflammatory bowel models) (1), tendon and connective tissue (5)(2), muscle and bone models (1), and neurological tissue through brain-gut axis interactions (4)

Purity is paramount

los valores citados en estudios de tendn y ligamento en rata varan segn el estudio y el endpoint

Arch Pharmacol